Erroneous reduction of HbA1c levels in patients with type 2 diabetes mellitus on dapsone treatment for Hansen's disease - a single-center retrospective cohort study.

Add to Collection

2022 May-Jun Observational studies GS Basavaraj, RD Gupta, B Patel, F Jebasingh… - Indian Journal of …, 2022 - ijdvl.com 131

Full Author : ['Basavaraj, G S', 'Gupta, Riddhi Das', 'Patel, Bhavesh', 'Jebasingh, Felix', 'George, Anu Anna', 'Peter, Dincy', 'George, Leni', 'Paul, Thomas V', 'Thomas, Nihal']
Journal Title : Indian journal of dermatology, venereology and leprology
Chapter : Section3
Journal Year : 2022
Cited by : 1.0

Background Dapsone treatment may reduce HbA1c levels in patients with diabetes. Aims To assess the prevalence and characteristics of dapsone associated reduction of HbA1c in patients with Hansen's disease. Methods A retrospective data review of outpatient..... Read More

Keywords : ["singlecenter retrospective cohort study", "type diabetes mellitus", "hansen disease", "erroneous reduction", "dapsone treatment", "patient", "level"]
PubMed Link : https://ijdvl.com/erroneous-reduction-of-hba1c-levels-in-patients-with-type-2-diabetes-mellitus-on-dapsone-treatment-for-hansens-disease-a-single-center-retrospective-cohort-study/
Google Scholar Link : https://scholar.google.com/scholar?cites=10385388799243072109&as_sdt=5,44&sciodt=0,44&hl=en&num=20

Have a Question?

Erroneous reduction of HbA1c levels in patients with type 2 diabetes mellitus on dapsone treatment for Hansen's disease - a single-center retrospective cohort study.